Similar articles

• [To lessen the cardiovascular risk of the diabetic patient. Atorvastatin of use for diabetic patients without coronary disease, too].

  [No authors listed] [No authors listed] MMW Fortschr Med. 2005 Aug 18;147(33-34):51. MMW Fortschr Med. 2005. PMID: 16138641 German. No abstract available.
• [CARDS confirms usefulness of LDL lowering in type 2 diabetics].

  Bern VH. Bern VH. Praxis (Bern 1994). 2004 Oct 27;93(44):1 p following 1830. Praxis (Bern 1994). 2004. PMID: 15559908 German. No abstract available.
• [Intensive LDL lowering to under 80 mg/dl: hypercholesteremia patients with stable coronary disease and diabetes profit especially significantly].

  [No authors listed] [No authors listed] MMW Fortschr Med. 2005 Aug 18;147(33-34):50-1. MMW Fortschr Med. 2005. PMID: 16138640 German. No abstract available.
• [Atorvastatin].

  Kajinami K, Takekoshi N. Kajinami K, et al. Nihon Rinsho. 2001 Mar;59 Suppl 3:598-604. Nihon Rinsho. 2001. PMID: 11347138 Review. Japanese. No abstract available.
• Combination therapy with ezetimibe and simvastatin to achieve aggressive LDL reduction.

  Robinson JG, Davidson MH. Robinson JG, et al. Expert Rev Cardiovasc Ther. 2006 Jul;4(4):461-76. doi: 10.1586/14779072.4.4.461. Expert Rev Cardiovasc Ther. 2006. PMID: 16918265 Review.